Sanofi (SNYNF) EPS (Basic) (2009 - 2026)

Sanofi (SNYNF) posted EPS (Basic) of -$6.35 for Q2 2026, down 504.67% sequentially from $1.57 in Q1 2026, and down 274.48% YoY from $3.64 in Q2 2025.

Sanofi (SNYNF) EPS (Basic) (2009 - 2026) Analysis & Trends

Sanofi has reported EPS (Basic) for 18 years, with the latest figure at -$6.35 in Q2 2026.

Quarterly EPS (Basic) fell 274.48% year-over-year to -$6.35 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$2.79 (down 133.99% YoY) and the FY2025 annual result came in at $7.45, up 56.96% from the prior year.
EPS (Basic) declined to -$6.35 in Q2 2026 per SNYNF's latest filing, from $1.57 in the prior quarter.
Over five years, EPS (Basic) peaked at $8.23 in Q3 2025 and troughed at -$6.35 in Q2 2026.
A 5-year average of $1.15 and a median of $1.58 in 2026 frame the typical range for EPS (Basic).
The widest YoY moves for EPS (Basic): up 279.36% in 2025, down 1580.29% in 2025.
Over 5 years, EPS (Basic) stood at $4.29 in 2022, then plunged by 111.13% to -$0.48 in 2023, then jumped by 189.32% to $0.43 in 2024, then plunged by 1580.29% to -$6.31 in 2025, then dropped by 0.67% to -$6.35 in 2026.
According to Business Quant data, EPS (Basic) over the past three periods registered -$6.35, $1.57, and -$6.31 for Q2 2026, Q1 2026, and Q4 2025 respectively.

Download Data